Navigation überspringen
Anti-Inflammatory Prevents Heart Attacks
Article

Anti-Inflammatory Prevents Heart Attacks

By vindicating theory, antibody result points to new approaches to protecting the heart

Science, 2017

automatisch generiertes Audio
automatisch generiertes Audio

Editorial Rating

7

Qualities

  • Innovative
  • Scientific

Recommendation

Would you pay a premium for a drug that could reduce heart disease and lung cancer? Early evidence suggests that a juvenile arthritis drug might offer hope to people at high risk for heart attacks and strokes. The anti-inflammatory properties of canakinumab might prevent atherosclerosis that leads to heart attacks. getAbstract suggests this article to those with an interest in the inflammation theory of heart disease.

Take-Aways

  • A 10,000-patient study confirms that inflammation plays a role in heart attacks.
  • The anti-inflammatory drug canakinumab targets the pathway responsible for atherosclerosis.
  • Canakinumab now treats juvenile arthritis. The United States’ Food and Drug Administration has yet to approve it for reducing heart disease.

About the Author

Jennifer Couzin-Frankel, a Science Magazine staff writer since 2002, attended Harvard University.


More on this topic

By the same author

Related Channels